The challenges of implementing CAR-T therapy in CLL

Challenges in the clinical implementation of the CAR T-cell therapy A2B694Подробнее

Overcoming challenges in CAR T-cell therapy for multiple myelomaПодробнее

CAR T-cell Therapy: Multiple MyelomaПодробнее

Answering the common challenges facing real-world CAR T-cell therapiesПодробнее

The challenges with CAR T-cell therapy for T-ALL and the progress made to overcome these challengesПодробнее

Current challenges in CAR-T cell therapy and the role of the tumor microenvironmentПодробнее

Documentary: Cell & Gene Therapy - Advancing The Next Generation of PharmaceuticalsПодробнее

CAR T-cells in Multiple MyelomaПодробнее

House Cancer Caucus Briefing: ImmunotherapiesПодробнее

Challenges that have been faced with developing CAR-T products for CLL and future outlooksПодробнее

Challenges with implementing CARs in CLL and the promise of allogeneic productsПодробнее

Addressing the major challenges to CAR-T therapy in AMLПодробнее

Future prospects for CAR-T cell therapy in AMLПодробнее

CAR-T in solid tumors: challenges and future directionsПодробнее

CAR-T Cell Therapies - Where are we now (edited for unpublished data)Подробнее

Using Clinical Pharmacology & Pharmacometrics to Accelerate CAR-T DevelopmentПодробнее

Engineered T Cells for CancerПодробнее

Moffitt Medical Minute: CAR T Cell Therapy for Solid TumorПодробнее

Key challenges in developing CAR-T therapy for CLLПодробнее

Challenges in developing CAR-T therapy for AMLПодробнее